Rockwell Automation and Case Western Reserve University Partnership
Title: Rockwell – Case PartnershipDate: 11/14/22
Related Articles
GARD Rare Disease Information – ROHHAD – National Organization for Rare Disorders
ROHHAD is an acronym for rapid-onset obesity (RO) with hypothalamic dysregulation (H), hypoventilation (H), and autonomic dysregulation (AD). It is a rare, life-threatening syndrome that…
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Efgartigimod significantly increased sustained platelet count responses compared with placebo in patients with chronic immune thrombocytopenia, including those who had received multiple previous immune thrombocytopenia…
The future of valvular heart disease assessment and therapy
Valvular heart disease (VHD) is becoming more prevalent in an ageing population, leading to challenges in diagnosis and management. This two-part Series offers a comprehensive…
Valvular heart disease: from mechanisms to management
Valvular heart disease is common and its prevalence is rapidly increasing worldwide. Effective medical therapies are insufficient and treatment was historically limited to the surgical…
I.M. Matters from ACP
I.M. Matters from ACP provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities…
Geriatric Emergency Medication Safety Recommendations (GEMS-Rx): Modified Delphi Development of a High-Risk Prescription List for Older Emergency Department Patients
Half of emergency department (ED) patients aged 65 years and older are discharged with new prescriptions. Potentially inappropriate prescriptions contribute to adverse drug events. Our…
Oral HAE Preventative Treatment | ORLADEYO® (berotralstat)
Discover the first oral therapy designed to prevent hereditary angioedema attacks. Find treatment info & see how ORLADEYO® is different.
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
In adults with overweight and obesity, phentermine–topiramate and GLP-1 receptor agonists proved the best drugs in reducing weight; of the GLP-1 agonists, semaglutide might be…
Global Physician Scholar (GPS) Program | ACP Online
ACP’s Global Physician Scholar (GPS) Program provides opportunities for early/mid career physicians from outside the United States and Canada to gain expertise in a focused…
Global Physician Scholar (GPS) Program | ACP Online
ACP’s Global Physician Scholar (GPS) Program provides opportunities for early/mid career physicians from outside the United States and Canada to gain expertise in a focused…